Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 4/20 | 0.50 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.50 |
| ▸ | CHRNB4 | P30926 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | GABRP | O00591 | 2/20 | 0.33 |
| ▸ | GABRD | O14764 | 2/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.33 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.33 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.33 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.33 |
| ▸ | GABRE | P78334 | 2/20 | 0.33 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.33 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.33 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2557841 | 0.87 | CHRNB2 (0.62) | CHRNB2CHRNA4CHRNB4ALDH1A1CYP1A2 | |
| SCHEMBL12410076 | 0.82 | CYP1A2 (0.60) | CHRNB2CHRNA4CHRNB4CYP1A2GABRP | |
| SCHEMBL15314151 | 0.82 | CYP1A2 (0.60) | CHRNB2CHRNA4CHRNB4CYP1A2GABRP | |
| SCHEMBL26373651 | 0.82 | CHRNB2 (0.50) | CHRNB2CHRNA4CHRNB4ALDH1A1CYP1A2 | |
| SCHEMBL12410078 | 0.82 | CYP1A2 (0.60) | CHRNB2CHRNA4CHRNB4ALDH1A1CYP1A2 | |
| SCHEMBL12410139 | 0.80 | CHRNB2 (0.48) | CHRNB2CHRNA4CHRNB4ALDH1A1CYP1A2 | |
| SCHEMBL4955330 | 0.80 | DPP4 (0.41) | CHRNB2CHRNA4CHRNB4CYP1A2GABRP | |
| SCHEMBL12410135 | 0.78 | CHRNB2 (0.47) | CHRNB2CHRNA4CHRNB4ALDH1A1CYP1A2 | |
| SCHEMBL23055054 | 0.78 | CA1 (0.43) | CHRNB2CHRNA4CHRNB4ALDH1A1CYP1A2 | |
| SCHEMBL1517765 | 0.78 | CHRNB2 (0.56) | CHRNB2CHRNA4CHRNB4ALDH1A1GABRP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240147998-A1 | HERBICIDAL COMPOSITIONS COMPRISING IMIDAZOLINONE-BASED ACETOLACTATE SYNTHASE INHIBITORS AND USES THEREOF | ADAMA AGAN LTD. (IL) | 2024-05-09 | — | — | US | disclosed |
| US-20230309560-A1 | SOLUBLE LIQUID COMPOSITIONS OF SAFLUFENACIL, METHOD OF PREPARATION AND USE THEREOF | ADAMA AGAN LTD. (IL) | 2023-10-05 | — | — | US | disclosed |
| US-20230210851-A1 | SPIRO-LACTAM COMPOUNDS AND METHODS OF TREATING VIRAL INFECTIONS USING THE SAME | APTINYX INC (US) | 2023-07-06 | — | — | US | disclosed |
| US-20230192693-A1 | SPIRO-LACTAM NMDA MODULATORS AND METHODS OF USING SAME | TENACIA BIOTECHNOLOGY (HONG KONG) CO., LIMITED (HK) | 2023-06-22 | — | — | US | disclosed |
| US-9392785-B2 | Use of esteramides as solvents, novel esteramides and process for preparing esteramides | RHODIA OPERATIONS (FR) | 2016-07-19 | — | — | US | disclosed |
| US-9392785-B2 | Use of esteramides as solvents, novel esteramides and process for preparing esteramides | RHODIA OPERATIONS (FR) | 2016-07-19 | — | — | US | disclosed |
| EP-2102148-B1 | NOVEL BIS(DIALKYLAMIDE) COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND USES THEREOF | RHODIA OPERATIONS (FR) | 2015-09-16 | — | — | EP | disclosed |
| EP-2102148-B1 | NOVEL BIS(DIALKYLAMIDE) COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND USES THEREOF | RHODIA OPERATIONS (FR) | 2015-09-16 | — | — | EP | disclosed |
| US-20140221211-A1 | USE OF ESTERAMIDES AS SOLVENTS, NOVEL ESTERAMIDES AND PROCESS FOR PREPARING ESTERAMIDES | RHODIA OPERATIONS (FR) | 2014-08-07 | — | — | US | disclosed |
| US-20140221211-A1 | USE OF ESTERAMIDES AS SOLVENTS, NOVEL ESTERAMIDES AND PROCESS FOR PREPARING ESTERAMIDES | RHODIA OPERATIONS (FR) | 2014-08-07 | — | — | US | disclosed |
| EP-2347652-A1 | Esteramides, their preparation and their use | Rhodia Opérations (FR) | 2011-07-27 | — | — | EP | disclosed |
| US-20110166025-A1 | ESTERAMIDE SOLVENTS/COALESCING AGENTS IN PHYTOSANITARY, CLEANING, DEGREASING, STRIPPING, LUBRICATING, COATING, AND PIGMENT/INK COMPOSITIONS | RHODIA OPERATIONS (FR) | 2011-07-07 | — | — | US | disclosed |
| US-20110166025-A1 | ESTERAMIDE SOLVENTS/COALESCING AGENTS IN PHYTOSANITARY, CLEANING, DEGREASING, STRIPPING, LUBRICATING, COATING, AND PIGMENT/INK COMPOSITIONS | RHODIA OPERATIONS (FR) | 2011-07-07 | — | — | US | disclosed |
| WO-2011036421-A1 | ORGANIC PHOTOVOLTAIC COATINGS WITH CONTROLLED MORPHOLOGY | RHODIA OPERATIONS (FR) | 2011-03-31 | — | — | WO | disclosed |
| US-20100113279-A1 | NOVEL BIS(DIALKYLAMIDE) COMPOUNDS AND DIVERSE APPLICATIONS THEREOF | SPECIALTY OPERATIONS FRANCE (FR) | 2010-05-06 | — | — | US | disclosed |
| US-20100113279-A1 | NOVEL BIS(DIALKYLAMIDE) COMPOUNDS AND DIVERSE APPLICATIONS THEREOF | SPECIALTY OPERATIONS FRANCE (FR) | 2010-05-06 | — | — | US | disclosed |
| US-20100113279-A1 | NOVEL BIS(DIALKYLAMIDE) COMPOUNDS AND DIVERSE APPLICATIONS THEREOF | SPECIALTY OPERATIONS FRANCE (FR) | 2010-05-06 | — | — | US | disclosed |
| EP-2102148-A1 | NOVEL BIS(DIALKYLAMIDE) COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND USES THEREOF | Rhodia Opérations (FR) | 2009-09-23 | — | — | EP | disclosed |
| WO-2008074837-A1 | NOVEL BIS(DIALKYLAMIDE) COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND USES THEREOF | RHODIA OPERATIONS (FR) | 2008-06-26 | — | — | WO | disclosed |
| WO-2008074837-A1 | NOVEL BIS(DIALKYLAMIDE) COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND USES THEREOF | RHODIA OPERATIONS (FR) | 2008-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166025-A1 | ESTERAMIDE SOLVENTS/COALESCING AGENTS IN PHYTOSANITARY, CLEANING, DEGREASING, STRIPPING, LUBRICATING, COATING, AND PIGMENT/INK COMPOSITIONS | ACHE, ITCH, SORT1 | CHRNB2 2883/4885CHRNA4 4509/4885CHRNB4 3852/4885 |
| US-20240147998-A1 | HERBICIDAL COMPOSITIONS COMPRISING IMIDAZOLINONE-BASED ACETOLACTATE SYNTHASE INHIBITORS AND USES THEREOF | PPOX, ACOX1, PAOX | CHRNB2 4152/4885CHRNA4 3817/4885CHRNB4 4185/4885 |
| US-20230309560-A1 | SOLUBLE LIQUID COMPOSITIONS OF SAFLUFENACIL, METHOD OF PREPARATION AND USE THEREOF | SLCO4C1, OTC, SORD | CHRNB2 4438/4885CHRNA4 4198/4885CHRNB4 4606/4885 |
| US-20230210851-A1 | SPIRO-LACTAM COMPOUNDS AND METHODS OF TREATING VIRAL INFECTIONS USING THE SAME | ACE, ACE2, PREP | CHRNB2 4866/4885CHRNA4 4835/4885CHRNB4 4845/4885 |
| US-20140221211-A1 | USE OF ESTERAMIDES AS SOLVENTS, NOVEL ESTERAMIDES AND PROCESS FOR PREPARING ESTERAMIDES | NOTUM, FADS2, CERS2 | CHRNB2 3773/4885CHRNA4 3978/4885CHRNB4 4240/4885 |
| US-20230192693-A1 | SPIRO-LACTAM NMDA MODULATORS AND METHODS OF USING SAME | GRIN1, GRIN2A, GRIN2C | CHRNB2 378/4885CHRNA4 96/4885CHRNB4 360/4885 |
| US-20100113279-A1 | NOVEL BIS(DIALKYLAMIDE) COMPOUNDS AND DIVERSE APPLICATIONS THEREOF | C1R, CBR3, CWC15 | CHRNB2 2978/4885CHRNA4 1757/4885CHRNB4 2156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.